홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
REPL
#2301
Replimune Group, Inc.
7.6
5
-2.30%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-2.30%
월간 변동
+1.73%
6달 변화
+37.84%
년간 변동율
-39.04%
이전 종가
7.8
3
Open
7.6
5
Bid
Ask
Low
7.6
5
High
7.6
5
양
97
마켓
주식
헬스케어
REPL
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
46.61 M
49.07 M
57.78 M
61.42 M
77.09 M
—
Valuation ratios
Enterprise value
1.24 B
727.26 M
873.73 M
400.28 M
640.48 M
2.17 B
Price to earnings ratio
—
-7.51
-5.91
-2.39
-3.18
-10.09
Price to sales ratio
—
—
181.12
667.43
3 907.96
12.63 K
Price to cash flow ratio
—
10.79
8.03
2.77
4.09
12.17
Price to book ratio
—
2.16
1.85
1.37
1.89
3.3
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.15
-0.26
-0.27
-0.44
-0.45
0.11
Return on equity %
-0.16
-0.29
-0.31
-0.58
-0.59
0.22
Return on invested capital %
-485.28
-709.53
-1 041.88
-1 308.09
-1 362.12
-795.35
Gross margin %
100
—
100
100
100
400
Operating margin %
-8 757.39
—
-3 119.8
-30.45 K
-130.16 K
-42.9 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
-8 857.61
—
-3 070.54
-27.99 K
-123.03 K
-18.11 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
33.25
19.46
17.52
10.72
7.95
26.8
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0.01
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.02
—
0.04
0.09
0.08
0.45
Long term debt to total equity ratio
0.02
—
0.05
0.12
0.11
0.66
Per share metrics
Operating cash flow per share
—
-1.57
-2.2
-2.79
-2.39
-3.11
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
7.58
10.02
6.32
6.01
16.87
Net current asset value per share
—
7.74
10.18
6.51
6.16
17.36
Tangible book value per share
—
7.88
9.54
5.63
5.16
14
Working capital per share
—
7.34
9.6
5.91
5.38
14.82
Book value per share
—
7.88
9.54
5.63
5.16
14
뉴스
Replimune Stock: Multiple Shots On Goal But A High Risk Binary Approaches (NASDAQ:REPL)
Wall Street Analysts Predict a 65.72% Upside in Replimune Group (REPL): Here's What You Should Know
Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
현재 공매도 잔고율 가장 높은 주식 10종목
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
The Short List — Top 10 Most Shorted Stocks Right Now - Lucid Group (NASDAQ:LCID)
Iovance Biotherapeutics: Several Positives, But Competition Still Threatens (NASDAQ:IOVA)
캔터 피츠제럴드, 레플리뮨 그룹에 ’비중확대’ 투자의견 유지
Cantor Fitzgerald reiterates Overweight rating on Replimune Group stock
레플리뮨, SITC 2025에서 흑색종 치료제 긍정적 데이터 발표
Replimune reports positive data for melanoma treatment at SITC 2025